COMP <GO>
CBIO vs CTMX // GROSS PROFIT MARGIN
Crescent Biopharma Inc. (NASDAQ) VS. CytomX Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CBIO 5
— CTMX 3
■ METRIC PARITY
LAST: $12.91 (-4.23%) • MKT CAP: $500.7M
gross-margins
—
LAST: $2.23 (-4.70%) • MKT CAP: $509.9M
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CBIO VS. CTMX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CBIO | CTMX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -20.50% | -14.50 | CTMX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.86% | -15.19% | +1.33 | CBIO | /fcf-yield <GO> |
| Operating Margin | -60.00% | -29.30% | -30.70 | CTMX | /operating-margins <GO> |
| Net Profit Margin | 1.40% | -22.80% | +24.20 | CBIO | /net-margins <GO> |
| Revenue Growth (YoY) | — | -44.80% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.36 | 0.20 | +6.16 | CBIO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 1/9 | +2.00 | CBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.5 | 43.5 | +3.00 | CBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $500.7M | $509.9M | -$9.2M | CTMX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CBIO REV | CTMX REV | CBIO GROSS % | CTMX GROSS % | CBIO FCF | CTMX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.8M | $76.2M | — | — | -$72.5M | -$75.8M |
| FY 2024 | $112.1M | $138.1M | — | — | -$31.1M | -$86.5M |
| FY 2023 | $110.0M | $101.2M | — | — | -$34.9M | -$56.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CBIO // BETA —
CTMX // BETA —